Drug Profile
DA 9201
Alternative Names: Oryza sativa extract - Dong-ALatest Information Update: 23 Jul 2015
Price :
$50
*
At a glance
- Originator Dong-A Pharmaceutical
- Developer Dong-A ST
- Class Antiasthmatics
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 06 Jul 2006 Preclinical trials in Asthma in South Korea (PO)